logo
Share SHARE
FONT-SIZE Plus   Neg

ZST Digital Networks To Delist From Nasdaq

ZST Digital Networks, Inc. (ZSTN) said Friday that its Board of Directors has decided to seek a voluntary delisting from the NASDAQ Global Market in view of the company's inability to continue to comply with the NASDAQ's continued listing requirements of making filings with the SEC on a timely basis.

BDO China Dahua CPA Co., Ltd. had previously informed ZST of its decision to resign as the company's independent registered public accounting firm, effective March 26. In addition, BDO had informed the company that BDO can no longer support its opinion dated March 3, 2011 relating to its audit of the company's consolidated financial statements for the year ended December 31, 2010 contained in its Form 10-K filed with the SEC on March 4, 2011. As a result, the company anticipates that it will be unable to file its annual report on Form 10-K for the fiscal year ended December 31, 2011 on a timely basis.

The company said it plans to file a Form 25 with the SEC on or about April 16, anticipates that the delisting of its common stock will become effective on or about April 26.

The company expects that its common stock will be eligible for trading on the over-the-counter market thereafter.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Shares of International Consolidated Airlines Group S.A. were gaining around 3 percent in London trading after the airline reported Friday higher profit in its second quarter, benefited by higher passenger revenues, despite weak cargo revenues. The company now expects low double digit percentage growth in pre-exceptional operating profit in 2016. Swiss banking giant UBS Group AG reported Friday a 14 percent decline in second quarter profit with weakness in net interest income. Looking ahead, the company said the difficult conditions continue to persist, yet the firm is well positioned to benefit from even a moderate improvement in conditions. UBS shares were gaining around 3 percent in the morning trading in Zurich. We are well into the third quarter and past the middle of the year and it is time to take stock of regulatory decisions awaiting some biotech stocks in August. Despite the uncertain macroeconomic environment, the markets have run up, with the S&P 500 Index making new highs session after session. Valuation concerns may keep traders at bay. However, the biotech space is a different cup of tea.
comments powered by Disqus
Follow RTT